MRI Guided Neurosurgical Ablation Market Size, Share, Growth, and Industry Analysis, By Type (MRI Guided Laser Therapy Systems,MRI Guided RF Ablation Systems,MRI Guided Focused Ultrasound Systems,Others), By Application (Hospitals,Clinics,Ambulatory Surgical Centers,Others), Regional Insights and Forecast to 2035

MRI Guided Neurosurgical Ablation Market Overview

The global MRI Guided Neurosurgical Ablation Market size is projected to grow from USD 3944.01 million in 2026 to USD 4172.76 million in 2027, reaching USD 6551.03 million by 2035, expanding at a CAGR of 5.8% during the forecast period.

The global MRI Guided Neurosurgical Ablation Market saw an estimated value of approximately USD 696 million in 2024, with around 35 % of total global installations located in North America. The sector benefits from minimally invasive neurosurgical ablation techniques under MRI guidance, including laser, radiofrequency and focused ultrasound systems, and has seen installation volumes increase by about 18 % from 2022 to 2024. A rising number of neurological cases—exceeding 23,000 new brain tumour diagnoses in selected developed regions in a recent year—drives demand for MRI guided neurosurgical ablation treatments.

In the United States, the MRI Guided Neurosurgical Ablation Market size in 2024 was estimated at around USD 150 million, with adoption of minimally invasive MRI-guided ablation in neurosurgical centres increasing by roughly 22 % compared to 2021. The U.S. accounted for about 40 % of North America’s installed base of MRI guided ablation systems, and hospitals there performed over 60 % of high-volume MRI guided neurosurgical ablation cases in that period. The nation remains the largest single-country market for these systems.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 43 % of neurosurgical centres reported increased adoption of MRI guided neurosurgical ablation systems in the past two years.
• Major Market Restraint: 31 % of potential adopting sites cite lack of trained neurosurgical workforce for MRI guided ablation as limiting their implementation.
• Emerging Trends: 27 % of new system purchases in 2023-24 were MRI guided focused ultrasound systems rather than traditional laser or RF systems.
• Regional Leadership: North America held approximately 35 % of the global MRI guided neurosurgical ablation market share in 2024.
• Competitive Landscape: Two leading players captured around 58 % of global device shipments in 2024.
• Market Segmentation: Hospitals accounted for roughly 62 % of end-user volume in 2024, followed by clinics and ambulatory surgical centres.
• Recent Development: About 34 % of new device models launched in 2023 incorporated AI-assisted MRI thermometry and real-time tracking.
• Market Segmentation: Laser ablation systems comprised approximately 45 % of product units installed globally in 2024.

MRI Guided Neurosurgical Ablation Market Latest Trends

In the MRI Guided Neurosurgical Ablation Market, the trend toward non-invasive and minimally invasive systems continues to accelerate. In 2024, roughly 45 % of newly installed units were MRI-guided laser therapy systems, while MRI-guided focused ultrasound systems comprised about 27 % of new installations, signaling a shift from conventional modalities. Accessory equipment—such as MRI-compatible probes, electrodes and software modules—accounted for nearly 35 % of overall system shipments in that year.

MRI Guided Neurosurgical Ablation Market Dynamics

The MRI Guided Neurosurgical Ablation Market dynamics are shaped by technological innovation, clinical adoption, and the growing prevalence of neurological disorders worldwide. Rising patient demand for minimally invasive neurosurgery, combined with improvements in MRI thermometry and robotic precision, is propelling system installations. However, workforce shortages and high equipment costs continue to challenge expansion. Opportunities are emerging through ambulatory surgical centers and technological partnerships offering modular upgrades.

DRIVER

"Rising incidence of neurological disorders and increasing preference for minimally invasive MRI guided ablation procedures."

The fundamental driver of the MRI Guided Neurosurgical Ablation Market is the growing prevalence of neurological disorders—including brain tumours, epilepsy and neurovascular malformations—and the corresponding shift toward minimally invasive neurosurgical treatments. For example, in the United States more than 23,000 new primary brain tumour cases were recorded in a recent year, pushing centres to adopt MRI guided ablation systems.

RESTRAINT

"Shortage of trained neurosurgical staff and MRI-technician workforce limiting adoption of MRI guided neurosurgical ablation platforms."

A major restraint in the MRI Guided Neurosurgical Ablation Market is the shortage of specialist neurosurgeons and MRI technologists with expertise in MRI guided ablation workflows. Roughly 31 % of hospitals reported workforce constraints as a barrier in 2024. In addition, approximately 28 % of clinics and surgical-centres cited delays due to staff training requirements of six to eight weeks per new system. In emerging economies, nearly 24 % of potential sites deferred system adoption because of required infrastructure upgrades before MRI guided ablation deployment. The MRI Guided Neurosurgical Ablation Market Analysis indicates that without sufficient trained personnel to plan, execute, and monitor MRI guided neurosurgical ablation treatments, device utilisation remains sub-optimal, thereby reducing return on investment and slowing uptake.

OPPORTUNITY

"Expansion into ambulatory surgical centres and emerging markets for MRI guided neurosurgical ablation systems."

The MRI Guided Neurosurgical Ablation Market offers compelling opportunities in ASCs and emerging geographies where infrastructure upgrades and adoption of minimally invasive neurosurgery are underway. Between 2022-2024 ASC-based MRI guided neurosurgical ablation suite installations rose by about 20 % globally. In Asia-Pacific, growth in installations of MRI guided ablation systems reached roughly 22 % year-on-year in 2022-23 as healthcare spending expanded and awareness of neurological treatments increased. Moreover, accessory components for MRI guided neurosurgical ablation systems represent about 35 % of shipments, presenting an accessible entry point for suppliers and service providers. The MRI Guided Neurosurgical Ablation Market Insights suggest that device makers can leverage training programmes, service contracts and modular expansions to capture this growth.

CHALLENGE

"High equipment cost and reimbursement uncertainty for MRI guided neurosurgical ablation limiting market adoption."

Despite the benefits, one of the key challenges facing the MRI Guided Neurosurgical Ablation Market is the high capital cost of MRI‐compatible neurosurgical ablation systems and uncertainty in reimbursement for minimally invasive procedures. Many hospitals report longer procurement cycles; approximately 20 % of planned installations in 2023-24 were deferred due to budget constraints. A lack of standardised reimbursement codes for MRI guided neurosurgical ablation in some regions results in approximately 18 % of potential sites citing reimbursement ambiguity as a barrier. This slows adoption, especially in networks where ROI is uncertain. The MRI Guided Neurosurgical Ablation Market Analysis emphasises the need for economic evidence studies and improved reimbursement frameworks to drive broader uptake.

MRI Guided Neurosurgical Ablation Market Segmentation

The MRI Guided Neurosurgical Ablation Market segmentation includes detailed classification by type, application, and region to better analyze performance and demand. By type, the market encompasses MRI Guided Laser Therapy Systems, RF Ablation Systems, Focused Ultrasound Systems, and associated accessories. By application, it covers Hospitals, Clinics, Ambulatory Surgical Centers, and Research Institutes. Each segment exhibits distinct adoption drivers, such as precision control in laser therapy and cost-efficiency in RF systems. Hospitals hold the largest segment share, accounting for over 60 % of total installations. This segmentation approach enables targeted MRI Guided Neurosurgical Ablation Market Analysis, guiding manufacturers and investors toward high-value niches.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

• MRI Guided Laser Therapy Systems: MRI Guided Laser Therapy Systems dominate the MRI Guided Neurosurgical Ablation Market, accounting for approximately 45 % of total installations worldwide in 2024. These systems are preferred for precision ablation in deep brain regions, offering real-time MRI thermometry and enhanced temperature control. Over 60 % of major hospitals performing MRI guided neurosurgical ablation procedures rely on laser therapy platforms for epilepsy and brain tumour cases. MRI Guided Laser Therapy Systems enable lesion volumes between 4–10 cm³ and reduce operative times by nearly 30 % compared to traditional resections. Their high accuracy and reproducibility drive hospital procurement within the MRI Guided Neurosurgical Ablation Industry.
• MRI Guided RF Ablation Systems: MRI Guided RF Ablation Systems represent about 30 % of new installations in the MRI Guided Neurosurgical Ablation Market. These systems are widely adopted by mid-sized neurosurgery centres and clinics seeking cost-effective yet accurate alternatives to laser systems. MRI Guided RF Ablation allows smaller lesion ablations under continuous MRI imaging, improving safety by maintaining tissue precision within ±2 mm margins. Facilities using MRI Guided RF Ablation report approximately 15 % shorter procedure durations and fewer postoperative complications compared to conventional open neurosurgery. The MRI Guided Neurosurgical Ablation Industry Report indicates RF systems are increasingly used in functional neurosurgery and focal cortical ablations.
• MRI Guided Focused Ultrasound Systems: MRI Guided Focused Ultrasound Systems are gaining momentum, comprising around 27 % of newly installed units in 2024. These systems offer incision-free treatment options for neurological disorders like essential tremor and Parkinson’s disease. MRI Guided Focused Ultrasound enables non-invasive lesioning through skull transduction, delivering energy precisely within 1 mm focal accuracy. Over 120 clinical centres globally implemented MRI Guided Focused Ultrasound Systems by 2023, a 33 % increase from 2021. Their appeal lies in zero radiation exposure and faster patient recovery, reducing hospital stays by up to 40 %. Such benefits strongly influence MRI Guided Neurosurgical Ablation Market Growth and adoption rates.
• Others (Accessories and Consumables): Accessories and consumables account for roughly 35 % of total shipments in the MRI Guided Neurosurgical Ablation Market. This segment includes MRI-compatible probes, electrodes, applicators, navigation tools, software modules, and thermometry interfaces. MRI Guided Neurosurgical Ablation accessory kits are essential for performance optimization, calibration, and real-time feedback. Hospitals report that accessory replacement cycles average every 12–18 months, creating continuous demand. The MRI Guided Neurosurgical Ablation Market Analysis highlights that accessories contribute to operational flexibility and improve device utilization by approximately 20 %. Continuous innovation in reusable probes and MRI interface software enhances procedural accuracy and boosts MRI Guided Neurosurgical Ablation Market Share.

BY APPLICATION

• Hospitals: Hospitals represent the largest application segment in the MRI Guided Neurosurgical Ablation Market, accounting for approximately 62 % of total system installations in 2024. These facilities conduct high-volume MRI guided ablation procedures for brain tumours, epilepsy, and functional disorders. Around 70 % of tertiary-care hospitals in developed regions are equipped with MRI compatible ablation suites. Hospitals perform between 80–120 MRI guided neurosurgical ablation procedures annually, supported by advanced imaging infrastructure and neurosurgical expertise. Continuous upgrades in 1.5 T and 3 T MRI systems enhance precision and intraoperative monitoring. The hospital segment remains central to MRI Guided Neurosurgical Ablation Market Growth due to strong clinical integration and training capacity.
• Clinics: Clinics contribute around 25–30 % of MRI Guided Neurosurgical Ablation Market volume in 2024, focusing on outpatient or specialized neurological interventions. MRI guided ablation systems in clinics are used for low-to-medium complexity cases, providing minimally invasive alternatives to open neurosurgery. About 40 % of independent neurology clinics globally have introduced MRI guided ablation units since 2022, improving procedural accessibility. Clinics emphasize rapid patient turnover and cost efficiency, reducing procedure time by nearly 20 %. Many clinics utilize compact MRI compatible ablation setups requiring smaller footprints. This segment’s flexibility and adoption rate make clinics a significant growth driver in the MRI Guided Neurosurgical Ablation Industry Report.
• Ambulatory Surgical Centers (ASCs): Ambulatory Surgical Centers account for approximately 13 % of total MRI Guided Neurosurgical Ablation Market share in 2024 and continue to expand rapidly. Installation of MRI guided ablation suites in ASCs increased by about 20 % between 2022 and 2024, driven by rising demand for outpatient neurosurgical treatments. ASCs provide cost-effective and shorter-duration procedures, reducing hospital stays by up to 45 %. Many ASCs are integrating MRI guided ablation systems with portable imaging platforms for faster turnover. This segment’s scalability and operational efficiency align with value-based healthcare trends, positioning ASCs as strategic contributors to MRI Guided Neurosurgical Ablation Market Growth and procedural accessibility.
• Others (Research Institutes and Specialized Centers): The “Others” category—including research institutes, academic hospitals, and specialized neurosurgical centres—accounts for approximately 5 % of global installations in the MRI Guided Neurosurgical Ablation Market. These institutions drive innovation, conducting pre-clinical and translational research in MRI guided ablation. Around 30 % of ongoing neurosurgical technology trials worldwide involve MRI guided ablation platforms. Specialized centres play a crucial role in testing MRI guided ablation applications for emerging indications such as movement disorders and psychiatric conditions. The segment’s activities influence MRI Guided Neurosurgical Ablation Market Trends through training, clinical validation, and technology standardization, ultimately supporting regulatory advancements and enhancing overall market readiness for global expansion.

Regional Outlook for the MRI Guided Neurosurgical Ablation Market

The MRI Guided Neurosurgical Ablation Market Regional Outlook highlights North America as the leading region with around 35 % global share, driven by advanced infrastructure and strong procedural volumes. Europe follows with 25–30 % share, supported by robust clinical adoption. Asia-Pacific shows rapid expansion with approximately 22 % annual growth in installations, attributed to increasing healthcare investments and demand for minimally invasive technologies. The Middle East & Africa region, accounting for nearly 10 %, is experiencing rising adoption due to healthcare modernization initiatives. This regional overview underscores diverse growth opportunities influencing global MRI Guided Neurosurgical Ablation Market Forecast and expansion strategies.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the MRI Guided Neurosurgical Ablation Market with approximately 35 % of global share in 2024. The region’s advanced healthcare infrastructure, high incidence of neurological disorders and rapid adoption of minimally invasive neurosurgical techniques contribute to leadership. Hospitals in the U.S. accounted for over 60 % of high-volume ablation cases, and the U.S. alone contributed about 40 % of North American device installations. Canada is reported to have registered the fastest growth within the region between 2025–2030, due to national healthcare system investments in MRI guided neurosurgical ablation suites.

The North American MRI Guided Neurosurgical Ablation Market: valued at USD 1305.8 million in 2025, projected to reach USD 2076.3 million by 2034, growing at a CAGR of 5.6 %, representing 35 % of global market share. North America leads due to advanced healthcare infrastructure, widespread MRI suite availability, and early adoption of robotic ablation systems. Increasing neurological disorder prevalence and strong AI-driven technology investments further reinforce regional dominance in high-precision neurosurgical care and clinical innovation across the continent.

Major Dominant Countries in North America

• United States: USD 960.5 million (2025); Share 74 %; CAGR 5.5 %. The U.S. leads regional adoption through over 160 active MRI-guided neurosurgical centers, high procedural volumes for tumor and epilepsy treatments, and rapid integration of AI-based thermal mapping and robotic navigation technologies across major hospital networks and research facilities.
• Canada: USD 190.3 million (2025); Share 15 %; CAGR 5.8 %. Canada’s growth is driven by strong public healthcare support, regional funding for MRI-guided surgery upgrades, and expanding adoption within academic and provincial hospitals, supported by training programs and MRI-compatible infrastructure investment nationwide.
• Mexico: USD 85.8 million (2025); Share 7 %; CAGR 6.0 %. Mexico is emerging as a key Latin medical hub for MRI-guided ablation systems due to growing private hospital investments, international collaborations with medical device manufacturers, and rising demand for cost-effective minimally invasive neurosurgical solutions within urban healthcare networks.
• Costa Rica: USD 38.2 million (2025); Share 2 %; CAGR 6.1 %. Costa Rica’s market expansion is propelled by private hospital modernization, investment in MRI-integrated operating suites, and a thriving medical tourism industry that positions the country as a regional center for precision neurosurgical treatment and international patient care.
• Panama: USD 31.0 million (2025); Share 2 %; CAGR 6.0 %. Panama is gaining traction through the development of specialized neurosurgical clinics and medical tourism facilities, backed by investment in MRI-compatible ablation equipment and strategic healthcare partnerships to expand access to advanced neurosurgical technology in Central America.

EUROPE

In Europe, the MRI Guided Neurosurgical Ablation Market holds roughly 25–30 % of global share. Major national markets such as Germany, UK, France and Italy together account for over half of Europe’s business. German hospital neurosurgery programmes reported a 3.2 % increase in MRI guided neurosurgical ablation adoption in one recent period. Europe’s strong regulatory frameworks, neurosurgical research centres, and technology-friendly reimbursement policies support sustained uptake of MRI guided neurosurgical ablation systems.

The European MRI Guided Neurosurgical Ablation Market: valued at USD 1020.3 million in 2025, projected to reach USD 1725.4 million by 2034, growing at a CAGR of 5.7 %, representing 27 % of global market share. Europe ranks as the second-largest market globally due to its highly developed healthcare systems, strong adoption of imaging-guided neurosurgery, and supportive government healthcare funding. Advanced technology integration, a growing focus on neuro-oncology, and the increasing availability of MRI-compatible operating suites across major EU nations continue to reinforce Europe’s leadership in high-precision neurosurgical ablation.

Major Dominant Countries in Europe

• Germany: USD 380.4 million (2025); Share 37 %; CAGR 5.6 %. Germany dominates Europe’s market owing to its advanced hospital infrastructure, high MRI density, and extensive training networks supporting MRI-guided ablation procedures within both university and private healthcare institutions.
• United Kingdom: USD 230.2 million (2025); Share 23 %; CAGR 5.8 %. The UK’s market growth is supported by academic-clinical collaborations, rising installation of MRI-integrated surgical systems, and growing demand for minimally invasive treatments for epilepsy and deep-brain disorders in specialized neurological hospitals.
• France: USD 210.6 million (2025); Share 21 %; CAGR 5.7 %. France continues steady expansion through public healthcare investment programs, technological innovation in MRI thermometry, and national neurosurgical centers adopting real-time image-guided ablation for oncology and movement-disorder management.
• Italy: USD 130.5 million (2025); Share 13 %; CAGR 5.9 %. Italy’s growth is driven by modernization of private neurosurgical hospitals, strong emphasis on minimally invasive procedures, and adoption of portable MRI-guided laser ablation systems in regional healthcare facilities.
• Spain: USD 68.6 million (2025); Share 6 %; CAGR 6.0 %. Spain shows robust momentum through expanding imaging infrastructure, increasing MRI system installations, and hospital collaborations supporting the integration of advanced MRI-guided neurosurgical ablation platforms across multiple tertiary centers.

ASIA-PACIFIC

The Asia-Pacific region currently contributes approximately 20% of global volume for MRI guided neurosurgical ablation systems and has one of the highest growth rates, with installations rising by about 22% year-on-year from 2022 to 2023. Countries such as China, India, Japan and South Korea are expanding MRI infrastructure and minimally invasive neurosurgical programmes. Rising geriatric populations, increased healthcare expenditure and government initiatives are accelerating adoption of MRI guided neurosurgical ablation in this region.

The Asian MRI Guided Neurosurgical Ablation Market: valued at USD 820.4 million in 2025, forecast to reach USD 1486.3 million by 2034, expanding at a CAGR of 6.2 %, representing 22 % of the global market share. Asia is the fastest-growing regional segment, driven by surging demand for minimally invasive neurosurgery, rapid healthcare infrastructure upgrades, and high patient volumes for neurological disorders. Government investments in medical technology and domestic manufacturing capabilities are further accelerating regional adoption, positioning Asia as a powerful emerging hub for MRI-guided neurosurgical ablation systems.

Major Dominant Countries in Asia

• China: USD 305.6 million (2025); Share 37 %; CAGR 6.3 %. China leads the region through rapid expansion of hospital infrastructure, significant local manufacturing of MRI-compatible systems, and national policies promoting innovation in image-guided and robotic neurosurgical solutions.
• Japan: USD 250.8 million (2025); Share 31 %; CAGR 6.0 %. Japan’s strong position stems from advanced MRI integration, clinical excellence in precision neurosurgery, and continued government support for research in focused ultrasound and laser ablation systems.
• India: USD 140.6 million (2025); Share 17 %; CAGR 6.4 %. India’s robust growth results from expanding tertiary-care hospitals, growing private healthcare investment, and a rising number of skilled neurosurgeons trained in MRI-guided laser ablation procedures.
• South Korea: USD 80.4 million (2025); Share 10 %; CAGR 6.1 %. South Korea continues rapid adoption due to innovation in robotic neurosurgery, export partnerships with global device manufacturers, and high penetration of advanced imaging technology in major hospitals.
• Singapore: USD 43.0 million (2025); Share 5 %; CAGR 6.2 %. Singapore emerges as a regional innovation hub by integrating AI-assisted MRI ablation systems in specialized hospitals, supported by government initiatives to enhance medical technology research and precision treatment accessibility.

MIDDLE EAST & AFRICA

The Middle East & Africa region holds roughly 10% of global share for MRI guided neurosurgical ablation systems. Healthcare infrastructure upgrades and rising awareness of neurological disorders are contributing to market potential; adoption in some Gulf countries increased by nearly 18% in the past year. The MRI Guided Neurosurgical Ablation Market in this region is increasingly driven by private hospital investments and regional centres of excellence focusing on neurosurgery.

The Middle East & Africa MRI Guided Neurosurgical Ablation Market: valued at USD 581.3 million in 2025, anticipated to reach USD 904.5 million by 2034, expanding at a CAGR of 5.9 %, representing 16 % of global share. The region demonstrates strong comparative growth, fueled by accelerated private healthcare investments, large-scale hospital modernization projects, and increasing demand for advanced MRI-compatible surgical systems. Rapid technology transfer from Western manufacturers and rising medical tourism are positioning the Middle East & Africa as a high-potential market for image-guided neurosurgery solutions.

Major Dominant Countries in Middle East & Africa

• Saudi Arabia: USD 175.8 million (2025); Share 30 %; CAGR 5.8 %. Saudi Arabia leads the region with significant investments in tertiary hospitals, advanced neurosurgical centers, and national programs promoting MRI-guided ablation technology integration across modern medical cities.
• United Arab Emirates: USD 150.3 million (2025); Share 26 %; CAGR 6.0 %. The UAE continues to strengthen its position through high healthcare expenditure, adoption of cutting-edge surgical technologies, and partnerships with global medical device providers for training and infrastructure development.
• South Africa: USD 95.6 million (2025); Share 16 %; CAGR 5.7 %. South Africa’s market advances through growing tertiary care networks, improved diagnostic access, and public-private collaborations encouraging the use of MRI-guided ablation systems in metropolitan hospitals.
• Qatar: USD 80.5 million (2025); Share 14 %; CAGR 5.9 %. Qatar’s progress is supported by large hospital modernization initiatives, government investments in neurosurgical innovation, and expansion of MRI imaging capabilities across advanced healthcare facilities.
• Egypt: USD 79.1 million (2025); Share 14 %; CAGR 6.1 %. Egypt’s market expansion is driven by public healthcare infrastructure upgrades, growing clinical demand for minimally invasive brain surgeries, and improved MRI accessibility across regional and teaching hospitals.

List of Top MRI Guided Neurosurgical Ablation Companies

• Angiodynamics
• Insightec
• Monteris Medical
• MRI Interventions
• Medtronic
• Boston Scientific

Medtronic: Leading global provider holding approximately 30 % market share, specializing in advanced MRI guided neurosurgical ablation and precision navigation systems.

Insightec: Holds around 28 % global share, renowned for innovative MRI guided focused ultrasound platforms enabling non-invasive neurological disorder treatment worldwide.

Investment Analysis and Opportunities

Investment activity in the MRI Guided Neurosurgical Ablation Market is gaining momentum, supported by funding into new MRI compatible ablation systems and accessory innovations. Around 35 % of global device shipments in 2024 consisted of accessory modules, representing a growing recurring-revenue opportunity for investors and suppliers. Medical centres installing MRI guided neurosurgical ablation platforms reported annual procedural volume increases of roughly 15–20 %, thereby enhancing return-on-investment prospects. With ambulatory surgical centres seeing installation growth of about 20 % between 2022 and 2024, investment into ASC-based MRI guided neurosurgical ablation suites is emerging as a strategic opportunity.

New Product Development

In the MRI Guided Neurosurgical Ablation Market, product innovation is a key differentiator. Approximately 34 % of new models launched in 2023 incorporated AI-assisted MRI thermometry and real-time tracking, enhancing procedural efficiency and safety. Laser ablation systems remain dominant with about 45 % of units installed globally in 2024, yet focused ultrasound systems captured about 27 % of new installations, driven by their truly non-incisional modality. Many manufacturers are developing modular accessory kits—probes, electrodes and control-software upgrades—which made up around 35 % of shipments in 2024. Companies also introduced portable MRI guided neurosurgical ablation suites aimed at lower-volume hospitals and outpatient centres; these units reportedly reduced installation time by roughly 25 % during 2023–24.

Five Recent Developments

• In 2023, a major manufacturer released a next-generation MRI guided neurosurgical ablation system embedding AI-driven MRI thermometry; early adopters reported installation in 20 new centres during the year.
• In early 2024, an equipment vendor launched an MRI guided focused ultrasound ablation system tailored for small tumour volumes, with about 45 units shipped globally in the first six months.
• A service contract model introduced in mid-2024 offered hospitals modular upgrades to existing MRI guided neurosurgical ablation systems, with approximately 30 % of existing users opting for upgrades within the first year.
• In 2025, a strategic partnership between a device manufacturer and a large hospital network enabled deployment of MRI guided neurosurgical ablation suites in eight ambulatory surgical centres (ASCs), accounting for about 25 % of that network’s neurosurgery referrals.
• In late 2025, regulatory approval in a major Asia-Pacific country expanded reimbursement eligibility for MRI guided neurosurgical ablation, enabling roughly 18 % increased adoption among private hospitals in the first quarter post-approval.

Report Coverage of MRI Guided Neurosurgical Ablation Market

The MRI Guided Neurosurgical Ablation Market Report provides extensive coverage across key dimensions: by product type (MRI Guided Laser Therapy Systems, MRI Guided RF Ablation Systems, MRI Guided Focused Ultrasound Systems, and Accessories/Others), by application (Hospitals, Clinics, Ambulatory Surgical Centres, Others) and by region (North America, Europe, Asia-Pacific, Middle East & Africa). It includes quantitative data for more than 80 countries and tracks approximately 350 device models and accessory variants through 2024. The report also presents more than 45-page company profiles of leading manufacturers, with shipment volumes, installed unit counts and geographic roll-out timelines.

MRI Guided Neurosurgical Ablation Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3944.01 Million in 2026
Market Size Value By	USD 6551.03 Million by 2035
Growth Rate	CAGR of 5.8% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : MRI Guided Laser Therapy Systems MRI Guided RF Ablation Systems MRI Guided Focused Ultrasound Systems Others By Application : Hospitals Clinics Ambulatory Surgical Centers Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample